A pioneering new treatment promises to tackle a wider range of cancers, with fewer side-effects than conventional ...

Johnson & Johnson , fresh off a $14.6 billion deal to buy neurological drugmaker Intra-Cellular , reported fourth-quarter ...

A man who shrank by three inches after developing a rare cancer has thanked a UK-leading team for extending his life. Peter ...

The cancer mortality rate continued to decline but increases in cancer in young people, women and populations of color are ...

Kirk Herbstreit wasn’t able to hold back his emotions after Ohio State won the national championship on Monday night at ...

Atara Biotherapeutics said on Tuesday the U.S. health regulator had placed a clinical hold on its trials for cancer cell ...

Rising diagnoses of certain cancers in people under 50 predate the rollout of COVID-19 vaccines by decades, undermining ...

Work to create a dedicated cancer hospital in Cambridge could begin this year, the government announced. Cambridge Cancer ...

India should eliminate tax on drugs for cancer treatment and for chronic and rare diseases, the chairperson of major ...

Good Morning America' co-anchor Michael Strahan opens up to PEOPLE about his daughter Isabella's aggressive brain cancer in ...

Recent results raise hope of new "broad, pan-tumor platform" like Keytruda. The emerging drugs are bispecific antibodies that ...

Peering into the body to find and diagnose cancer is all about spotting patterns. Radiologists use x-rays and magnetic ...